Helicobacter pylori infection and current clinical areas of contention
Authors:
- Peter MalfertheinerPMPeter Malfertheiner
- Michael SelgradMSMichael Selgrad
- 1 November 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 26 (6) , 618-623
Abstract
The indication for Helicobacter pylori (H. pylori) eradication has been extended to few extragastroduodenal diseases. Scientific rigor needs to be applied as the list of clinical manifestations potentially related to H. pylori has disproportionally grown to its scientific evidence. Some potential beneficial aspects of H. pylori in allergic diseases and in the context of obesity are critically addressed in this review. The main challenge, however, continues to be the prevention of gastric cancer by H. pylori eradication. Strategies for identification of individuals and populations at risk are reported as well. A final aspect is dedicated to novel treatment regimens for overcoming the increasing treatment failures with proton pump inhibitor-based triple standards. H. pylori infection is associated with some extragastric diseases such as idiopathic thrombocytic purpura and iron deficiency anemia that benefit from eradication therapy. The inverse relation of H. pylori prevalence and the increase in allergies and obesity, as reported from epidemiological studies, has prompted research for elucidating potential underlying pathophysiological mechanisms. Strategies for gastric cancer prevention include serological screening, which allow adopting eradication therapy in individuals at high risk. New treatments for H. pylori include sequential, bismuth-based quadruple and nonbismuth-based quadruple therapies. The main clinical challenge remains prevention of H. pylori-related diseases by effective treatment and screening procedures.Keywords
This publication has 53 references indexed in Scilit:
- Iron deficiency anaemia can be improved after eradication of Helicobacter pyloriPostgraduate Medical Journal, 2010
- Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trialsScandinavian Journal of Gastroenterology, 2010
- Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for preventionJournal of Digestive Diseases, 2010
- Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpuraHematology, 2009
- Helicobacters and Extragastric DiseasesHelicobacter, 2009
- Role of type IV secretion inHelicobacter pyloripathogenesisCellular Microbiology, 2008
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Immune Response to CagA Protein is Associated with Improved Platelet Count After Helicobacter pylori Eradication in Patients with Idiopathic Thrombocytopenic PurpuraHelicobacter, 2007
- Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemiaClinica Chimica Acta, 2005
- Regression of autoimmune thrombocytopenia after eradication of Helicobacter pyloriThe Lancet, 1998